These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16781449)

  • 1. Role of epithelial nitric oxide in airway viral infection.
    Xu W; Zheng S; Dweik RA; Erzurum SC
    Free Radic Biol Med; 2006 Jul; 41(1):19-28. PubMed ID: 16781449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and L-arginine deficiency in cystic fibrosis.
    Grasemann H; Ratjen F
    Curr Pharm Des; 2012; 18(5):726-36. PubMed ID: 22229575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and protein nitration in the cystic fibrosis airway.
    Morrissey BM; Schilling K; Weil JV; Silkoff PE; Rodman DM
    Arch Biochem Biophys; 2002 Oct; 406(1):33-9. PubMed ID: 12234487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism.
    Grasemann H; Storm van's Gravesande K; Gärtig S; Kirsch M; Büscher R; Drazen JM; Ratjen F
    Nitric Oxide; 2002 Mar; 6(2):236-41. PubMed ID: 11890749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nitric oxide in the regulation of ion channels in airway epithelium: implications for diseases of the lung.
    Duszyk M; Radomski MW
    Free Radic Res; 2000 Nov; 33(5):449-59. PubMed ID: 11200078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis.
    Zheng S; De BP; Choudhary S; Comhair SA; Goggans T; Slee R; Williams BR; Pilewski J; Haque SJ; Erzurum SC
    Immunity; 2003 May; 18(5):619-30. PubMed ID: 12753739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice.
    Mhanna MJ; Ferkol T; Martin RJ; Dreshaj IA; van Heeckeren AM; Kelley TJ; Haxhiu MA
    Am J Respir Cell Mol Biol; 2001 May; 24(5):621-6. PubMed ID: 11350833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis.
    Meng QH; Springall DR; Bishop AE; Morgan K; Evans TJ; Habib S; Gruenert DC; Gyi KM; Hodson ME; Yacoub MH; Polak JM
    J Pathol; 1998 Mar; 184(3):323-31. PubMed ID: 9614386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.
    Guo FH; De Raeve HR; Rice TW; Stuehr DJ; Thunnissen FB; Erzurum SC
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7809-13. PubMed ID: 7544004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, iNOS, and inflammation in cystic fibrosis.
    Downey D; Elborn JS
    J Pathol; 2000 Feb; 190(2):115-6. PubMed ID: 10657007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase.
    Gabbay E; Walters EH; Orsida B; Whitford H; Ward C; Kotsimbos TC; Snell GI; Williams TJ
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2182-7. PubMed ID: 11112135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.
    Grasemann H; Al-Saleh S; Scott JA; Shehnaz D; Mehl A; Amin R; Rafii M; Pencharz P; Belik J; Ratjen F
    Am J Respir Crit Care Med; 2011 May; 183(10):1363-8. PubMed ID: 21278301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium.
    Zheng S; Xu W; Bose S; Banerjee AK; Haque SJ; Erzurum SC
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L374-81. PubMed ID: 15107292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioenergetic Differences in the Airway Epithelium of Lean
    Winnica D; Corey C; Mullett S; Reynolds M; Hill G; Wendell S; Que L; Holguin F; Shiva S
    Antioxid Redox Signal; 2019 Oct; 31(10):673-686. PubMed ID: 30608004
    [No Abstract]   [Full Text] [Related]  

  • 15. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.
    Kelley TJ; Drumm ML
    J Clin Invest; 1998 Sep; 102(6):1200-7. PubMed ID: 9739054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene.
    Grasemann H; Knauer N; Büscher R; Hübner K; Drazen JM; Ratjen F
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2172-6. PubMed ID: 11112133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary metabolism of nitric oxide (NO) in patients with cystic fibrosis].
    Grasemann H; Ratjen F
    Pneumologie; 2002 Jun; 56(6):376-81. PubMed ID: 12063621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.
    Thomas SR; Kharitonov SA; Scott SF; Hodson ME; Barnes PJ
    Chest; 2000 Apr; 117(4):1085-9. PubMed ID: 10767244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis.
    Ho LP; Innes JA; Greening AP
    Eur Respir J; 1998 Dec; 12(6):1290-4. PubMed ID: 9877479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
    Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
    Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.